|
|
|
|
|
CUSIP NO. 75629F109
|
|
13G
|
|
Page
10
of 14 Pages
|
Item 1(a).
|
Name of Issuer:
|
Recro Pharma, Inc. (the Issuer)
Item 1(b).
|
Address of Issuers Principal Executive Offices:
|
490 Lapp Road, Malvern, Pennsylvania 19355
Item 2(a).
|
Name of Person Filing:
|
This statement (this Statement) is filed by the following persons (the Reporting Persons):
Athyrium Opportunities II Acquisition LP (AOII Acquisition LP)
Athyrium Opportunities III Acquisition LP (AOIII Acquisition LP and, together with AOII Acquisition LP, the
Acquisition Funds)
Athyrium Opportunities Associates II LP (Associates II LP)
Athyrium GP Holdings LLC (GP Holdings)
Athyrium Funds GP Holdings LLC (Funds GP Holdings)
Athyrium Opportunities Associates III LP (Associates III LP)
Athyrium Opportunities Associates III GP LLC (Associates III GP)
Jeffrey Ferrell (Mr. Ferrell)
The Reporting Persons beneficial ownership of the Issuers Common Stock (as defined below), reported herein consist of
(i) shares of Common Stock held directly by the Acquisition Funds and (ii) the Issuers Common Stock Purchase Warrants (the Warrants). Each of the Acquisition Funds directly owns Warrants exercisable for 174,332
shares of Common Stock at an exercise price of approximately $1.73 per share, as adjusted from time to time pursuant to the terms of the Warrants.
Pursuant to Rule 13d-1(k) promulgated under the Securities Exchange Act of 1934, as amended, the
Reporting Persons have entered into an agreement with respect to the joint filing of this Statement, which agreement is set forth on the signature page to this Statement.
Item 2(b).
|
Address of Principal Business Office or, if none, Residence:
|
The principal business office address for each of the Reporting Persons is: c/o Athyrium Capital Management, LP, 505 Fifth Avenue, Floor 18,
New York, New York 10017
The Acquisition Funds, Associates II LP, and Associates III LP are Delaware limited partnerships.
GP Holdings, Funds GP Holdings and Associates III GP are Delaware limited liability companies.
Mr. Ferrell is a United States citizen.
Item 2(d).
|
Title of Class of Securities:
|
Shares of common stock, nominal value $0.01 per share, of the Issuer (the Common Stock)
75629F109